Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dymatic Chemicals,Inc. (002054.SZ)
Foshan, CN
Dymatic Chemicals, Inc. is a Chinese manufacturer and supplier, primarily focusing on textile processing chemicals and a diverse array of other specialized chemical products. Its extensive product portfolio encompasses items such as pretreatment agents, dyeing auxiliaries, finishing agents, printing chemicals, specialty chemicals, cyclopentane, and innofarm products. The company was established in 1989 and maintains its headquarters in Foshan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.69% | +1.62% | +0.92% | -17.36% | +3.55% | +18.70% | +35.81% | +20.66% | -6.01% | +0.81% | +251.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-1.9% Q1'26: +23.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+92.3% ★ Q1'26: +45.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.0% Q1'26: -7.7% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+7.9% ★ Q1'26: +9.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+3.5% ★ Q1'26: +5.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.6% ★ Q1'26: +2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×4.45× Q1'26: 8.93× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|
| Revenue |
1.63B
est: 1.27B (+27.8%)
|
1.88B
est.
|
2.00B
est: 5.26B (-62.0%)
|
3.27B
est: 8.28B (-60.5%)
|
3.08B
est: 8.28B (-62.8%)
|
3.06B
est: 9.88B (-69.1%)
|
| EBITDA |
214.81M
est: 128.88M (+66.7%)
|
190.58M
est.
|
269.19M
est: 532.74M (-49.5%)
|
182.07M
est: 838.93M (-78.3%)
|
197.17M
est: 838.93M (-76.5%)
|
350.53M
est: 2.12B (-83.5%)
|
| EBIT |
143.66M
est: 66.16M (+117.2%)
|
97.83M
est.
|
222.75M
est: 273.47M (-18.5%)
|
85.49M
est: 430.64M (-80.1%)
|
6.95M
est: 430.64M (-98.4%)
|
135.87M
est: 520.14M (-73.9%)
|
| Net Income |
116.39M
est: 108.60M (+7.2%)
|
186.52M
est.
|
206.22M
est: 269.15M (-23.4%)
|
86.42M
est: 439.14M (-80.3%)
|
30.33M
est: 439.14M (-93.1%)
|
60.99M
est: 542.82M (-88.8%)
|
| SGA |
312.29M
est: 100.26M (+211.5%)
|
148.26M
est.
|
331.87M
est: 414.43M (-19.9%)
|
328.57M
est: 652.62M (-49.7%)
|
338.23M
est: 652.62M (-48.2%)
|
335.14M
est: 1.03B (-67.4%)
|
| EPS |
0.28
est: 0.23 (+21.7%)
|
0.40
est.
|
0.43
est: 0.57 (-24.6%)
|
0.18
est: 0.93 (-80.6%)
|
0.06
est: 0.93 (-93.2%)
|
0.13
est: 1.15 (-88.7%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guo Ying He | Deputy GM & Director | — | male |
| Min Chong Zhu | Deputy GM & Secretary of the Board of Directors | — | male |
| Mingzhi Zhang | Deputy General Manager | — | male |
| Shangdong Huang | GM & Director | — | male |
| Wei Xu | Accounting Supervisor | — | — |
| Xin Gong Xu | Deputy General Manager | — | male |
| Zhi Ming Ou | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002054.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
